OK Biotech Co., Ltd. (TPE:4155)
16.15
-0.15 (-0.92%)
Jul 18, 2025, 1:35 PM CST
OK Biotech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
1,730 | 1,670 | 1,192 | 1,484 | 1,263 | 1,484 | Upgrade | |
Revenue Growth (YoY) | 41.44% | 40.11% | -19.65% | 17.42% | -14.89% | 19.59% | Upgrade |
Cost of Revenue | 1,392 | 1,394 | 995.1 | 1,139 | 1,077 | 1,158 | Upgrade |
Gross Profit | 338.34 | 275.66 | 196.88 | 344.96 | 186.83 | 325.96 | Upgrade |
Selling, General & Admin | 205.17 | 177.25 | 148.41 | 156.09 | 148.24 | 152.14 | Upgrade |
Research & Development | 51.96 | 57.93 | 46.71 | 48.73 | 28.74 | 45.46 | Upgrade |
Other Operating Expenses | -4.06 | -6.29 | -7.43 | 7.06 | -4.93 | -8.07 | Upgrade |
Operating Expenses | 272.43 | 218.44 | 208.95 | 243.15 | 178.74 | 199.86 | Upgrade |
Operating Income | 65.9 | 57.21 | -12.06 | 101.81 | 8.09 | 126.1 | Upgrade |
Interest Expense | -7.02 | -6.23 | -9 | -11.42 | -8.08 | -8.12 | Upgrade |
Interest & Investment Income | 5.76 | 6.1 | 7.15 | 4.43 | 1.3 | 2.1 | Upgrade |
Earnings From Equity Investments | 2.18 | 5.11 | 5.33 | 7.43 | 24.65 | 38.61 | Upgrade |
Currency Exchange Gain (Loss) | 33.26 | 49.28 | -9.86 | 59.91 | -9.19 | -30.26 | Upgrade |
Other Non Operating Income (Expenses) | 15.66 | 13.33 | 23.69 | 18.04 | 28.26 | 22.51 | Upgrade |
EBT Excluding Unusual Items | 115.74 | 124.8 | 5.24 | 180.2 | 45.03 | 150.94 | Upgrade |
Impairment of Goodwill | - | - | - | -6 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -0.88 | - | - | - | 0.19 | - | Upgrade |
Gain (Loss) on Sale of Assets | 2.31 | 2.31 | 2.78 | 1.4 | 0.92 | 0.72 | Upgrade |
Pretax Income | 117.16 | 127.11 | 8.03 | 175.59 | 46.14 | 151.66 | Upgrade |
Income Tax Expense | 21.67 | 20.79 | 9.62 | 38.87 | 14.72 | 30.35 | Upgrade |
Earnings From Continuing Operations | 95.49 | 106.32 | -1.59 | 136.73 | 31.42 | 121.3 | Upgrade |
Minority Interest in Earnings | -12.83 | -12.34 | 4.54 | 6.74 | 12.04 | 8.43 | Upgrade |
Net Income | 82.67 | 93.98 | 2.95 | 143.46 | 43.46 | 129.73 | Upgrade |
Net Income to Common | 82.67 | 93.98 | 2.95 | 143.46 | 43.46 | 129.73 | Upgrade |
Net Income Growth | 293.30% | 3087.75% | -97.95% | 230.09% | -66.50% | 3.16% | Upgrade |
Shares Outstanding (Basic) | 142 | 143 | 128 | 105 | 104 | 92 | Upgrade |
Shares Outstanding (Diluted) | 146 | 146 | 128 | 130 | 118 | 100 | Upgrade |
Shares Change (YoY) | 6.77% | 14.02% | -1.41% | 9.95% | 18.84% | 16.16% | Upgrade |
EPS (Basic) | 0.58 | 0.66 | 0.02 | 1.37 | 0.42 | 1.42 | Upgrade |
EPS (Diluted) | 0.57 | 0.64 | 0.02 | 1.16 | 0.41 | 1.32 | Upgrade |
EPS Growth | 302.57% | 3119.04% | -98.28% | 182.57% | -68.83% | -10.49% | Upgrade |
Free Cash Flow | -337.35 | -310.79 | -426.74 | -46.31 | -57.16 | 67.91 | Upgrade |
Free Cash Flow Per Share | -2.32 | -2.12 | -3.32 | -0.36 | -0.48 | 0.68 | Upgrade |
Dividend Per Share | 0.300 | 0.300 | 0.300 | 1.115 | 0.907 | 1.270 | Upgrade |
Dividend Growth | - | - | -73.11% | 22.95% | -28.58% | -3.44% | Upgrade |
Gross Margin | 19.55% | 16.51% | 16.52% | 23.25% | 14.79% | 21.96% | Upgrade |
Operating Margin | 3.81% | 3.43% | -1.01% | 6.86% | 0.64% | 8.49% | Upgrade |
Profit Margin | 4.78% | 5.63% | 0.25% | 9.67% | 3.44% | 8.74% | Upgrade |
Free Cash Flow Margin | -19.50% | -18.61% | -35.80% | -3.12% | -4.52% | 4.58% | Upgrade |
EBITDA | 135.9 | 125.25 | 60.32 | 165.94 | 59.73 | 171.2 | Upgrade |
EBITDA Margin | 7.85% | 7.50% | 5.06% | 11.19% | 4.73% | 11.53% | Upgrade |
D&A For EBITDA | 70 | 68.04 | 72.38 | 64.13 | 51.64 | 45.1 | Upgrade |
EBIT | 65.9 | 57.21 | -12.06 | 101.81 | 8.09 | 126.1 | Upgrade |
EBIT Margin | 3.81% | 3.43% | -1.01% | 6.86% | 0.64% | 8.49% | Upgrade |
Effective Tax Rate | 18.50% | 16.36% | 119.86% | 22.13% | 31.90% | 20.01% | Upgrade |
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.